http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101883091-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-824
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101883091-B1
titleOfInvention Bilayered composite formulation comprising angiotensin recepter blocker and HMG-CoA reductase inhibitor and preparation method thereof
abstract The present invention relates to a first layer containing a Telmisartan solid dispersion; And a second layer containing pravastatin or a pharmaceutically acceptable salt thereof, wherein the two-pack combination preparation is stable in the stability of telmisartan and pravastatin from the point of strong acidity It has been found that the bioavailability can be improved at a time when the cholesterol synthesis and the blood pressure increase are maximized by effectively releasing the drug in a field of basic condition of pH 6.8. As a result of providing a combination agent containing two drugs, It is possible to improve convenience of taking.
priorityDate 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013345182-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23677803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452476757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972

Total number of triples: 47.